Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYGB | P11216 | 8/20 | 1.00 |
| ▸ | PYGL | P06737 | 3/20 | 0.59 |
| ▸ | PYGM | P11217 | 2/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | GBA1 | P04062 | 1/20 | 0.35 |
| ▸ | ADSS2 | P30520 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4313854 | 0.83 | PYGB (1.00) | PYGBPYGLPYGMLMNAGBA1 | |
| SCHEMBL4309389 | 0.83 | PYGB (0.71) | PYGBPYGLPYGMLMNAGBA1 | |
| SCHEMBL4316291 | 0.76 | PYGB (0.61) | PYGBPYGLPYGM | |
| SCHEMBL29941045 | 0.74 | PYGB (1.00) | PYGBPYGLPYGMLMNAGBA1 | |
| SCHEMBL4330413 | 0.72 | PYGB (1.00) | PYGBPYGLPYGMLMNAGBA1 | |
| Hydantocidin SCHEMBL8072284 | 0.69 | PYGB (0.90) | PYGBPYGLPYGMLMNAGBA1 | |
| Hydantocidin SCHEMBL8074132 | 0.69 | PYGB (0.90) | PYGBPYGLPYGMLMNAGBA1 | |
| Hydantocidin SCHEMBL10339110 | 0.69 | PYGB (0.90) | PYGBPYGLPYGMLMNAGBA1 | |
| SCHEMBL3712330 | 0.63 | PYGB (0.47) | PYGBPYGLPYGMLMNAGBA1 | |
| SCHEMBL7052003 | 0.63 | PYGB (0.47) | PYGBPYGLPYGMLMNAGBA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210254056-A1 | IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS | CAMP4 THERAPEUTICS CORPORATION | 2021-08-19 | — | — | US | disclosed |
| US-10877035-B2 | Advanced drug development and manufacturing | ICAGEN, LLC (US) | 2020-12-29 | — | — | US | disclosed |
| US-20150309021-A1 | Advanced Drug Development and Manufacturing | LOS ALAMOS NATIONAL SECURITY, LLC | 2015-10-29 | — | — | US | disclosed |
| EP-2511844-B1 | X-ray microscope | XRPRO SCIENCES INC (US) | 2015-08-12 | — | — | EP | disclosed |
| EP-2511844-A2 | Advanced drug development and manufacturing | Los Alamos National Security, LLC (US) | 2012-10-17 | — | — | EP | disclosed |
| EP-2084519-B1 | X-RAY FLUORESCENCE ANALYSIS METHOD | LOS ALAMOS NAT SECURITY LLC (US) | 2012-08-01 | — | — | EP | disclosed |
| EP-2084519-A2 | ADVANCED DRUG DEVELOPMENT AND MANUFACTURING | Los Alamos National Security, LLC (US) | 2009-08-05 | — | — | EP | disclosed |
| WO-2008127291-A2 | ADVANCED DRUG DEVELOPMENT AND MANUFACTURING | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2008-10-23 | — | — | WO | disclosed |
| US-20080220441-A1 | Advanced drug development and manufacturing | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2008-09-11 | — | — | US | disclosed |